Profile
Setareh van Driel Shamsili served as the Chief Medical Officer & Senior Vice President at Merus NV from 2012 to 2016.
He also worked as the Global Medical Leader-Oncology at Astellas Pharma Global Development, Inc. He later became the Chief Medical Officer at Ryvu Therapeutics SA from 2019 to 2022.
Dr. van Driel Shamsili holds a doctorate degree from Erasmus University Rotterdam and a graduate degree from Tehran University of Medical Sciences.
Former positions of Setareh van Driel Shamsili
| Companies | Position | End |
|---|---|---|
| RYVU THERAPEUTICS S.A. | Chief Tech/Sci/R&D Officer | 2022-01-31 |
| MERUS N.V. | Chief Tech/Sci/R&D Officer | 2015-12-31 |
Astellas Pharma Global Development, Inc.
 Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Global Development, Inc. provides business services. The company is headquartered in Deerfield, IL. | Corporate Officer/Principal | - |
Training of Setareh van Driel Shamsili
| Erasmus University Rotterdam | Doctorate Degree |
| Tehran University of Medical Sciences | Graduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| MERUS N.V. | Health Technology |
| RYVU THERAPEUTICS S.A. | Health Technology |
| Private companies | 1 |
|---|---|
Astellas Pharma Global Development, Inc.
Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Global Development, Inc. provides business services. The company is headquartered in Deerfield, IL. | Health Technology |
- Stock Market
- Insiders
- Setareh van Driel Shamsili
